Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers
Clinical trial NCT04934124 · COMPLETED
Trial details
- NCT number
- NCT04934124
- Sponsor
- Intra-Cellular Therapies, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-23
- Primary completion
- 2021-08-23
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.